Buy Halozyme Therapeutics Stock | HALO Stock Price & Latest News | Public
HALO

Halozyme Therapeutics

$0.00 (0.00%)Today

    About HALO

    Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0.52
    0.33
    0.14
    -0.04
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    $0.52

    Actual EPS
    Q4 2020

    Stats

    Market Cap$5,43B
    Volume40,76k
    Price-to-Earnings Ratio262.26
    Dividend Rate
    Dividend Yield
    1 Year High$41.55
    1 Year Low$12.71
    Open$41.26
    High$41.43
    Low$39.57

    Buy any stock with any amount of money.

    Download the App
    Download the app